CDH2 and breast cancer: The results showed that the downregulation of Talin-1 clearly decreased the expression of integrin β3, N-cadherin, and MMP-2 in the ESCs compared with the BC group and NC group, whereas the expression of E-cadherin increased (Fig. 5).